IBDEI0XF ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14884,1,4,0)
 ;;=4^K72.10
 ;;^UTILITY(U,$J,358.3,14884,2)
 ;;=^5008807
 ;;^UTILITY(U,$J,358.3,14885,0)
 ;;=K76.5^^85^836^43
 ;;^UTILITY(U,$J,358.3,14885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14885,1,3,0)
 ;;=3^Hepatic veno-occlusive disease
 ;;^UTILITY(U,$J,358.3,14885,1,4,0)
 ;;=4^K76.5
 ;;^UTILITY(U,$J,358.3,14885,2)
 ;;=^56249
 ;;^UTILITY(U,$J,358.3,14886,0)
 ;;=B15.0^^85^836^44
 ;;^UTILITY(U,$J,358.3,14886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14886,1,3,0)
 ;;=3^Hepatitis A,Acute w/ Coma
 ;;^UTILITY(U,$J,358.3,14886,1,4,0)
 ;;=4^B15.0
 ;;^UTILITY(U,$J,358.3,14886,2)
 ;;=^5000535
 ;;^UTILITY(U,$J,358.3,14887,0)
 ;;=B15.9^^85^836^45
 ;;^UTILITY(U,$J,358.3,14887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14887,1,3,0)
 ;;=3^Hepatitis A,Acute w/o Coma
 ;;^UTILITY(U,$J,358.3,14887,1,4,0)
 ;;=4^B15.9
 ;;^UTILITY(U,$J,358.3,14887,2)
 ;;=^5000536
 ;;^UTILITY(U,$J,358.3,14888,0)
 ;;=B16.0^^85^836^46
 ;;^UTILITY(U,$J,358.3,14888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14888,1,3,0)
 ;;=3^Hepatitis B,Acute w/ Coma & Delta
 ;;^UTILITY(U,$J,358.3,14888,1,4,0)
 ;;=4^B16.0
 ;;^UTILITY(U,$J,358.3,14888,2)
 ;;=^5000537
 ;;^UTILITY(U,$J,358.3,14889,0)
 ;;=B16.2^^85^836^47
 ;;^UTILITY(U,$J,358.3,14889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14889,1,3,0)
 ;;=3^Hepatitis B,Acute w/ Coma no Delta
 ;;^UTILITY(U,$J,358.3,14889,1,4,0)
 ;;=4^B16.2
 ;;^UTILITY(U,$J,358.3,14889,2)
 ;;=^5000539
 ;;^UTILITY(U,$J,358.3,14890,0)
 ;;=B16.1^^85^836^48
 ;;^UTILITY(U,$J,358.3,14890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14890,1,3,0)
 ;;=3^Hepatitis B,Acute w/ Delta no Coma
 ;;^UTILITY(U,$J,358.3,14890,1,4,0)
 ;;=4^B16.1
 ;;^UTILITY(U,$J,358.3,14890,2)
 ;;=^5000538
 ;;^UTILITY(U,$J,358.3,14891,0)
 ;;=B16.9^^85^836^49
 ;;^UTILITY(U,$J,358.3,14891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14891,1,3,0)
 ;;=3^Hepatitis B,Acute,Uncomplicated
 ;;^UTILITY(U,$J,358.3,14891,1,4,0)
 ;;=4^B16.9
 ;;^UTILITY(U,$J,358.3,14891,2)
 ;;=^5000540
 ;;^UTILITY(U,$J,358.3,14892,0)
 ;;=B19.10^^85^836^52
 ;;^UTILITY(U,$J,358.3,14892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14892,1,3,0)
 ;;=3^Hepatitis B,Unspec w/o Coma
 ;;^UTILITY(U,$J,358.3,14892,1,4,0)
 ;;=4^B19.10
 ;;^UTILITY(U,$J,358.3,14892,2)
 ;;=^5000552
 ;;^UTILITY(U,$J,358.3,14893,0)
 ;;=B17.0^^85^836^56
 ;;^UTILITY(U,$J,358.3,14893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14893,1,3,0)
 ;;=3^Hepatitis D,Acute Superinfection
 ;;^UTILITY(U,$J,358.3,14893,1,4,0)
 ;;=4^B17.0
 ;;^UTILITY(U,$J,358.3,14893,2)
 ;;=^5000541
 ;;^UTILITY(U,$J,358.3,14894,0)
 ;;=B17.2^^85^836^57
 ;;^UTILITY(U,$J,358.3,14894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14894,1,3,0)
 ;;=3^Hepatitis E,Acute
 ;;^UTILITY(U,$J,358.3,14894,1,4,0)
 ;;=4^B17.2
 ;;^UTILITY(U,$J,358.3,14894,2)
 ;;=^5000543
 ;;^UTILITY(U,$J,358.3,14895,0)
 ;;=Z12.89^^85^836^59
 ;;^UTILITY(U,$J,358.3,14895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14895,1,3,0)
 ;;=3^Hepatocellular carcinoma screening
 ;;^UTILITY(U,$J,358.3,14895,1,4,0)
 ;;=4^Z12.89
 ;;^UTILITY(U,$J,358.3,14895,2)
 ;;=^5062697
 ;;^UTILITY(U,$J,358.3,14896,0)
 ;;=R16.2^^85^836^61
 ;;^UTILITY(U,$J,358.3,14896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14896,1,3,0)
 ;;=3^Hepatomegaly w/ Splenomegaly NEC
 ;;^UTILITY(U,$J,358.3,14896,1,4,0)
 ;;=4^R16.2
 ;;^UTILITY(U,$J,358.3,14896,2)
 ;;=^5019250
 ;;^UTILITY(U,$J,358.3,14897,0)
 ;;=R16.0^^85^836^60
